The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal curcumin and standard radiation and temozolomide for newly diagnosed high-grade gliomas: A phase 1/2 study.
 
Matthias Holdhoff
Honoraria - Novartis
Consulting or Advisory Role - Anheart Therapeutics; Bayer; Novartis; SERVIER
Research Funding - Bristol Myers Squibb Foundation (Inst); SignPath Pharma (Inst); Vanquish Oncology (Inst)
Other Relationship - Advarra; Parexel
 
Solmaz Sahebjam
Consulting or Advisory Role - Pliant; Telix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - 62/040,579
 
Peng Huang
No Relationships to Disclose
 
David Kamson
Consulting or Advisory Role - SERVIER
Research Funding - AACR
 
Michaella Iacoboni
No Relationships to Disclose
 
Tamara Dobson-Brown
No Relationships to Disclose
 
Karisa Schreck
Honoraria - Novartis
Consulting or Advisory Role - Advarra; Nurix
Research Funding - Springworks Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Fore Biotherapeutics
 
Lawrence Kleinberg
No Relationships to Disclose
 
Kristin Redmond
Honoraria - Accuray
Consulting or Advisory Role - BioMimetics
Research Funding - Accucay; Canon Medical System; Icotec
Patents, Royalties, Other Intellectual Property - Canon Medical System
Travel, Accommodations, Expenses - Brainlab; Icotec
 
Victoria Croog
No Relationships to Disclose
 
Carmen Kut
Stock and Other Ownership Interests - Moderna Therapeutics (I); Pfizer (I)
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - MODELING THE IMPACT OF LYMPHOCYTE KINETICS ON SURVIVAL OUTCOMES IN HEAD AND NECK CANCER VIA AN ENSEMBLE TREE-BASED MACHINE LEARNING APPROACH; Quantitative tissue property mapping for real time tumor detection and interventional guidance. Patent EP3122238A1/US20170086675A1
 
Byram Ozer
No Relationships to Disclose
 
Stuart Grossman
No Relationships to Disclose
 
Michelle Comas
Employment - SignPath Pharma
Leadership - SignPath Pharma
Stock and Other Ownership Interests - SignPath Pharma
Research Funding - SignPath Pharma
Travel, Accommodations, Expenses - SignPath Pharma
 
Jonathan Plehn
Employment - SignPath Pharma
Leadership - SignPath Pharma
Consulting or Advisory Role - Haya Therapeutics
 
Joy Fisher
No Relationships to Disclose
 
Peter Sordillo
Employment - SignPath Pharma
Leadership - SignPath Pharma
Stock and Other Ownership Interests - SignPath Pharma
Honoraria - SignPath Pharma
Consulting or Advisory Role - SignPath Pharma
Research Funding - SignPath Pharma
Patents, Royalties, Other Intellectual Property - SignPath Pharma